Biovista Pvt Ltd

Clinical Evidence in Favor of Echinacea (IMMUNOCARE®).
Echinacea (IMMUNOCARE®) research during the past few years has primarily focused on its therapeutic benefits in treating symptoms of the common cold. A review of several clinical studies comprised of over 3,900 patients demonstrates that Echinacea (IMMUNOCARE®) decrease the frequency, symptoms & severity in cold & flu.

Zepelin et.al Curr Med Res Opin 1999; 15:214-227.

Five randomized, double blind, placebo controlled studies involving a total of 825 subjects supported the use of
Echinacea (IMMUNOCARE®) for the treatment of acute upper respiratory or flu like infections.

The ABC Clinical Guide to Herbs.

In a randomized, double-blind, placebo-controlled trial, 282 subjects aged 18-65 years with a history of two or more colds in the previous year were randomized to receive either Echinacea (IMMUNOCARE®) or placebo.The total daily symptom scores were found to be 23.1% lower in the Echinacea (IMMUNOCARE®) group than in placebo. Early intervention with a standardized formulation of Echinacea (IMMUNOCARE®) resulted in reduced
symptom severity in subjects with naturally acquired upper respiratory tract infection.

J Clin Pharm Ther 2004 Feb.; 29 (1) : 75-83.

Safety & Tolerability of Echinacea (IMMUNOCARE®).
The British herbal pharmacopoeia, the British herbal compendium, and the Encyclopedia of common natural ingredients list no contraindication for Echinacea (IMMUNOCARE®). It also suggests it has an excellent safety
profile and no side effects.

Alternative Medicine Review, vol.6, no. 4,2001.

Echinacea (IMMUNOCARE®) was well tolerated and clinically effective in alleviating symptoms more rapidly than placebo in patients with a common cold.

Arzneimittel Forschung 2001; 51(7): 563-568.


			Prevents Cold & Flu Cold & flu, a Common Problem. Common cold & flu remains one of the common health ailments affecting a huge population. Antihistamines, the most frequently prescribed medicines cause a range of undesired effects. There is need for a treatment, which can be used with the onset of symptoms to control cold & flu problem at an early stage. The Role of IMMUNOCARE® (Echinacea). Echinacea (IMMUNOCARE®) has been the subject of over 350 scientific studies examining its immune-enhancing & infection- fighting properties. Echinacea (IMMUNOCARE®) have been shown to activate white blood cells & promote enhanced function. Echinacea (IMMUNOCARE®) appears to offer benefits especially in common cold & upper respiratory tract infections. Murray Michael, The Guide to Natural Medicines, 2002 (626) Additional Advantages of IMMUNOCARE®. IMMUNOCARE® is a specially formulated product as orange flavored chewable tablets ensuring increased patient compliance. IMMUNOCARE® also contains vitamin C, which has proven favorable effects in cold and flu.
	Clinical Evidence in Favor of Echinacea (IMMUNOCARE®). Echinacea (IMMUNOCARE®) research during the past few years has primarily focused on its therapeutic benefits in treating symptoms of the common cold. A review of several clinical studies comprised of over 3,900 patients demonstrates that Echinacea (IMMUNOCARE®) decrease the frequency, symptoms & severity in cold & flu. Zepelin et.al Curr Med Res Opin 1999; 15:214-227. Five randomized, double blind, placebo controlled studies involving a total of 825 subjects supported the use of Echinacea (IMMUNOCARE®) for the treatment of acute upper respiratory or flu like infections. The ABC Clinical Guide to Herbs. In a randomized, double-blind, placebo-controlled trial, 282 subjects aged 18-65 years with a history of two or more colds in the previous year were randomized to receive either Echinacea (IMMUNOCARE®) or placebo.The total daily symptom scores were found to be 23.1% lower in the Echinacea (IMMUNOCARE®) group than in placebo. Early intervention with a standardized formulation of Echinacea (IMMUNOCARE®) resulted in reduced symptom severity in subjects with naturally acquired upper respiratory tract infection. J Clin Pharm Ther 2004 Feb.; 29 (1) : 75-83. Safety & Tolerability of Echinacea (IMMUNOCARE®). The British herbal pharmacopoeia, the British herbal compendium, and the Encyclopedia of common natural ingredients list no contraindication for Echinacea (IMMUNOCARE®). It also suggests it has an excellent safety profile and no side effects. Alternative Medicine Review, vol.6, no. 4,2001. Echinacea (IMMUNOCARE®) was well tolerated and clinically effective in alleviating symptoms more rapidly than placebo in patients with a common cold. Arzneimittel Forschung 2001; 51(7): 563-568.